Clarivate provides information services and software platforms serving academic institutions, government agencies, and life sciences and pharmaceutical companies across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company operates through three primary segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare.
The Academia & Government segment delivers research intelligence and library solutions, including the Web of Science platform for scientific research tracking, ProQuest content databases for academic institutions, and library management software such as Alma. The Intellectual Property segment offers patent search and analysis tools (Derwent Innovation and Derwent World Patents Index), trademark management solutions (CompuMark), IP portfolio management platforms (IPfolio), and administrative services for patent and trademark recordal. The Life Sciences & Healthcare segment provides regulatory intelligence platforms, drug safety and competitive intelligence tools (Cortellis), and specialized solutions for medical device companies.
Headquartered in London and incorporated in Jersey, Clarivate employs approximately 12,000 people. The company was originally founded in 1864 and previously operated under the name Clarivate Analytics Plc before rebranding in 2020. It is listed on the New York Stock Exchange.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.30 | $-0.30 | +68.7% | |
| 2024 | $-0.96 | $-0.96 | +34.7% | |
| 2023 | $-1.47 | $-1.47 | +76.4% | |
| 2022 | $-6.24 | $-5.97 | -3020.0% | |
| 2021 | $-0.20 | $-0.20 | +20.0% | |
| 2020 | $-0.25 | $-0.28 | +10.7% | |
| 2019 | $-0.28 | $-0.28 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-24 | 0001764046-26-000019 | SEC ↗ |
| 2024-12-31 | 2025-02-19 | 0001764046-25-000011 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0001764046-24-000016 | SEC ↗ |
| 2022-12-31 | 2023-03-01 | 0001764046-23-000012 | SEC ↗ |
| 2021-12-31 | 2022-03-10 | 0001764046-22-000064 | SEC ↗ |
| 2020-12-31 | 2021-02-26 | 0001764046-21-000022 | SEC ↗ |
| 2019-12-31 | 2020-03-02 | 0001104659-20-027484 | SEC ↗ |